Regulon

Regulon: R-509

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
16-0.86781810Pr-153Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1663 ENSG00000013573 DDX11 Q96FC9
6626 ENSG00000077312 SNRPA P09012
7514 ENSG00000082898 XPO1 O14980
79968 ENSG00000092470 WDR76 Q9H967
4174 ENSG00000100297 MCM5 P33992
5411 ENSG00000100941 PNN Q9H307
1869 ENSG00000101412 E2F1 Q01094
23178 ENSG00000115687 PASK Q96RG2
84705 ENSG00000130299 GTPBP3 Q969Y2
23225 ENSG00000132182 NUP210 Q8TEM1
9401 ENSG00000160957 RECQL4 O94761
64783 ENSG00000162775 RBM15 Q96T37
993 ENSG00000164045 CDC25A P30304
10036 ENSG00000167670 CHAF1A Q13111
5426 ENSG00000177084 POLE Q07864
8241 ENSG00000182872 RBM10 A0A0S2Z4X1

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TROXACITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor20
CLOFARABINEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
EDIFOLIGIDE SODIUME2F1OligonucleotideINHIBITORE2F inhibitor30
CYTARABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor41
GEMCITABINE HYDROCHLORIDERRM1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
SELINEXORXPO1Small moleculeINHIBITORExportin-1 inhibitor42
GEMCITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
ASPACYTARABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor20
FLUDARABINE PHOSPHATEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor41

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-509

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs